Detailed information for compound 1475682

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 293.51 | Formula: C19H37N2+
  • H donors: 1 H acceptors: 0 LogP: 3.83 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: C[N+](CCCCCNCC12CC3CC(C2)CC(C1)C3)(C)C
  • InChi: 1S/C19H37N2/c1-21(2,3)8-6-4-5-7-20-15-19-12-16-9-17(13-19)11-18(10-16)14-19/h16-18,20H,4-15H2,1-3H3/q+1
  • InChiKey: IWYZMMIPAJDJBN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni pyruvate kinase 0.0074 0.4457 0.4457
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0142 0.9905 0.9905
Plasmodium vivax pyruvate kinase, putative 0.0144 1 1
Mycobacterium ulcerans pyruvate kinase 0.0144 1 0.5
Schistosoma mansoni rab6-interacting 0.0024 0.05 0.05
Echinococcus granulosus lipoxygenase domain containing protein 0.0024 0.05 0.05
Leishmania major pyruvate kinase 0.0144 1 0.5
Loa Loa (eye worm) pyruvate kinase 0.0144 1 1
Plasmodium falciparum pyruvate kinase 2 0.0074 0.4457 0.4165
Echinococcus granulosus nuclear factor of activated T cells 5 0.0089 0.5663 0.5663
Brugia malayi pyruvate kinase 0.003 0.1011 0.0538
Trypanosoma brucei pyruvate kinase 1, putative 0.0144 1 0.5
Loa Loa (eye worm) pyruvate kinase 0.0144 1 1
Loa Loa (eye worm) pyruvate kinase 0.0144 1 1
Echinococcus granulosus pyruvate kinase 0.0144 1 1
Loa Loa (eye worm) hypothetical protein 0.0144 1 1
Echinococcus granulosus arachidonate 5 lipoxygenase 0.0142 0.9905 0.9905
Leishmania major pyruvate kinase 0.0144 1 0.5
Echinococcus granulosus pyruvate kinase 0.0074 0.4457 0.4457
Chlamydia trachomatis pyruvate kinase 0.0144 1 0.5
Entamoeba histolytica pyruvate kinase, putative 0.01 0.6554 0.5
Echinococcus granulosus RUN 0.0024 0.05 0.05
Schistosoma mansoni loxhd1 0.0024 0.05 0.05
Onchocerca volvulus Pyruvate kinase homolog 0.0144 1 1
Echinococcus multilocularis nuclear factor of activated T cells 5 0.0089 0.5663 0.5663
Echinococcus multilocularis pyruvate kinase 0.0113 0.7601 0.7601
Schistosoma mansoni rab6-interacting 0.0024 0.05 0.05
Schistosoma mansoni pyruvate kinase 0.0144 1 1
Echinococcus granulosus pyruvate kinase 0.0144 1 1
Loa Loa (eye worm) hypothetical protein 0.01 0.6554 0.6554
Loa Loa (eye worm) pyruvate kinase-PB 0.01 0.6554 0.6554
Plasmodium vivax pyruvate kinase 2, putative 0.0074 0.4457 0.4165
Plasmodium falciparum pyruvate kinase 0.0144 1 1
Echinococcus multilocularis pyruvate kinase 0.0144 1 1
Loa Loa (eye worm) doublecortin family protein 0.0024 0.05 0.05
Schistosoma mansoni polycystin 1-related 0.0024 0.05 0.05
Echinococcus multilocularis lipoxygenase domain containing protein 0.0024 0.05 0.05
Echinococcus multilocularis Polycystic kidney disease protein 0.0024 0.05 0.05
Schistosoma mansoni hypothetical protein 0.0024 0.05 0.05
Echinococcus multilocularis pyruvate kinase 0.0074 0.4457 0.4457
Brugia malayi Pyruvate kinase, M2 isozyme 0.0144 1 1
Toxoplasma gondii pyruvate kinase PyK1 0.0144 1 1
Echinococcus granulosus pyruvate kinase 0.0074 0.4457 0.4457
Loa Loa (eye worm) hypothetical protein 0.0024 0.05 0.05
Trichomonas vaginalis pyruvate kinase, putative 0.0144 1 0.5
Onchocerca volvulus Pyruvate kinase homolog 0.0144 1 1
Trypanosoma cruzi pyruvate kinase 2, putative 0.0144 1 0.5
Mycobacterium tuberculosis Probable pyruvate kinase PykA 0.0144 1 0.5
Schistosoma mansoni lipoxygenase 0.01 0.6507 0.6507
Echinococcus multilocularis lipoxygenase domain containing protein 0.0024 0.05 0.05
Echinococcus granulosus pyruvate kinase 0.0074 0.4457 0.4457
Trypanosoma brucei pyruvate kinase 1 0.0144 1 0.5
Brugia malayi Pyruvate kinase, alpha/beta domain containing protein 0.0043 0.2058 0.164
Giardia lamblia Pyruvate kinase 0.0144 1 1
Schistosoma mansoni pyruvate kinase 0.0144 1 1
Trichomonas vaginalis pyruvate kinase, putative 0.0144 1 0.5
Echinococcus multilocularis pyruvate kinase 0.0074 0.4457 0.4457
Onchocerca volvulus Pyruvate kinase homolog 0.0144 1 1
Echinococcus multilocularis RUN 0.0024 0.05 0.05
Trypanosoma cruzi pyruvate kinase 2, putative 0.0144 1 0.5
Loa Loa (eye worm) pyruvate kinase 0.003 0.1011 0.1011
Echinococcus multilocularis pyruvate kinase 0.0144 1 1
Schistosoma mansoni lipoxygenase 0.0142 0.9905 0.9905
Echinococcus granulosus lipoxygenase domain containing protein 0.0024 0.05 0.05
Mycobacterium leprae Probable pyruvate kinase PykA 0.0144 1 0.5
Echinococcus multilocularis pyruvate kinase 0.0074 0.4457 0.4457
Brugia malayi pyruvate kinase, muscle isozyme 0.003 0.1011 0.0538
Loa Loa (eye worm) hypothetical protein 0.0024 0.05 0.05
Echinococcus granulosus Polycystic kidney disease protein 0.0024 0.05 0.05

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.